drugset / Trial / NCT04599205

Evaluation of Laser and Tranexamic Acid in Treatment of Melasma

NCT04599205

Phase 2/3 Unknown 40 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

Melasma Is an acquired, chronic, recurrent, symmetrical hypermelanosis, which is characterized by brown patches of variable darkness on sun exposed areas of the body. It is more common in women. It is common psychologically and emotionally distressing cosmetic problem in affected patients .

Timeline

Start
2020-12
Primary completion
2021-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule Topical